Key facts
- It has raised $2.6M; the latest was Later Stage VC in Aug 2025.
- Notable investors include Peregrine Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Endomatic
- ·The full record, as it builds
Funding rounds
No funding rounds for Endomatic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Endomatic
Developer of a catheter-based closure device designed to close the left atrial appendage. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Or Yehuda, Israel
- Founded
- 2018
- Ownership
- Privately Held (backing)
Endomatic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Endomatic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Endomatic in its N-PORT filings yet. We sweep new filings monthly.